Viewing Study NCT02806505


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-03-01 @ 5:39 AM
Study NCT ID: NCT02806505
Status: COMPLETED
Last Update Posted: 2016-10-31
First Post: 2016-06-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-06
Start Date Type: None
Primary Completion Date: 2007-08
Primary Completion Date Type: ACTUAL
Completion Date: 2007-08
Completion Date Type: ACTUAL
First Submit Date: 2016-06-16
First Submit QC Date: None
Study First Post Date: 2016-06-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-09-09
Results First Submit QC Date: None
Results First Post Date: 2016-10-31
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-09-09
Last Update Post Date: 2016-10-31
Last Update Post Date Type: ESTIMATED